Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Comparison of pioglitazone and linagliptin in type 2 diabetes mellitus
IRCT20170513033941N66Phase 3Completed
- Sponsor
- Kashan University of Medical Sciences
- Start
- Sep 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial in type 2 diabetes mellitus (T2DM) comparing Pioglitazone with Linagliptin (2 arms). Started Sep 2019; status: completed.
02
Drugs
pioglitazonelinagliptin
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on IRCT20170513033941N66.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20170513033941N66.